GGrantIndex
← Leaderboards

James G Tidball

University Of California Los Angeles

$18,225,068
Attributed
$18,225,068
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$18,225,068 · 11

By mechanism

R01$15,782,231 · 9
T32$2,070,157 · 1
R21$372,680 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Muscle

Research focus

MuscleInvestigationCellsMacrophageInjuryMediatingAffectMyeloid CellsPhenotypeCytokineMolecularNatural RegenerationMuscle RegenerationInsightTransgenesRegenerativeIn VivoGrowthImmune SystemMuscle FibersPathway InteractionsMouse ModelBaseAblation

Grant awards (69)

Novel mechanisms regulating muscle growth and regeneration: elucidating the Klotho/Jmjd3/Wnt axis$332,904
R01 · FY2024 · AR · contact PI
Novel mechanisms regulating muscle growth and regeneration: elucidating the Klotho/Jmjd3/Wnt axis$343,200
R01 · FY2023 · AR · contact PI
Developing co-stimulatory blockade as a therapeutic strategy for Duchenne muscular dystrophy$341,250
R01 · FY2023 · NS · contact PI
Developing co-stimulatory blockade as a therapeutic strategy for Duchenne muscular dystrophy$341,250
R01 · FY2022 · NS · contact PI
Novel mechanisms regulating muscle growth and regeneration: elucidating the Klotho/Jmjd3/Wnt axis$339,768
R01 · FY2022 · AR · contact PI
Developing co-stimulatory blockade as a therapeutic strategy for Duchenne muscular dystrophy$341,250
R01 · FY2021 · NS · contact PI
Novel mechanisms regulating muscle growth and regeneration: elucidating the Klotho/Jmjd3/Wnt axis$332,904
R01 · FY2021 · AR · contact PI
Novel mechanisms regulating muscle growth and regeneration: elucidating the Klotho/Jmjd3/Wnt axis$343,200
R01 · FY2020 · AR · contact PI
Developing co-stimulatory blockade as a therapeutic strategy for Duchenne muscular dystrophy$341,250
R01 · FY2020 · NS · contact PI
Developing co-stimulatory blockade as a therapeutic strategy for Duchenne muscular dystrophy$341,250
R01 · FY2019 · NS · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$404,514
R01 · FY2018 · AR · contact PI
Immune cell regulation of the regeneration of dystrophic muscle$338,800
R01 · FY2018 · AR · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$338,800
R01 · FY2017 · AR · contact PI
Immune cell regulation of the regeneration of dystrophic muscle$338,800
R01 · FY2017 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$113,570
T32 · FY2017 · GM · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$48,913
R01 · FY2017 · AR · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$338,800
R01 · FY2016 · AR · contact PI
Immune cell regulation of the regeneration of dystrophic muscle$338,800
R01 · FY2016 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$167,808
T32 · FY2016 · GM · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$338,800
R01 · FY2015 · AR · contact PI
Immune cell regulation of the regeneration of dystrophic muscle$338,800
R01 · FY2015 · AR · contact PI
Functions of myelomonocytic lineage cells in aging muscle$306,229
R01 · FY2015 · AG · contact PI
Targeting Therapeutic Molecules to Dystrophic Muscle via the Immune System$169,400
R21 · FY2015 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$165,838
T32 · FY2015 · GM · contact PI
Myeloid-cell mediated mechanisms driving muscle growth and regeneration$338,800
R01 · FY2014 · AR · contact PI
Immune cell regulation of the regeneration of dystrophic muscle$338,800
R01 · FY2014 · AR · contact PI
Functions of myelomonocytic lineage cells in aging muscle$315,700
R01 · FY2014 · AG · contact PI
Targeting Therapeutic Molecules to Dystrophic Muscle via the Immune System$203,280
R21 · FY2014 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$163,920
T32 · FY2014 · GM · contact PI
Functions of myelomonocytic lineage cells in aging muscle$298,337
R01 · FY2013 · AG · contact PI
Training in Molecular, Cellular & Integrative Physiology$162,002
T32 · FY2013 · GM · contact PI
Functions of myelomonocytic lineage cells in aging muscle$130,615
R01 · FY2013 · AG · contact PI
Functions of myelomonocytic lineage cells in aging muscle$315,700
R01 · FY2012 · AG · contact PI
Training in Molecular, Cellular & Integrative Physiology$130,361
T32 · FY2012 · GM · contact PI
Myeloid cell function in muscle injury and repair$363,756
R01 · FY2011 · AR · contact PI
Functions of myelomonocytic lineage cells in aging muscle$315,700
R01 · FY2011 · AG · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$308,383
R01 · FY2011 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$151,208
T32 · FY2011 · GM · contact PI
Myeloid cell function in muscle injury and repair$321,233
R01 · FY2010 · AR · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$321,233
R01 · FY2010 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$149,394
T32 · FY2010 · GM · contact PI
Myeloid cell function in muscle injury and repair$14,420
R01 · FY2010 · AR · contact PI
Myeloid cell function in muscle injury and repair$324,478
R01 · FY2009 · AR · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$324,478
R01 · FY2009 · AR · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$214,386
R01 · FY2009 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$148,512
T32 · FY2009 · GM · contact PI
Myeloid cell function in muscle injury and repair$324,478
R01 · FY2008 · AR · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$324,478
R01 · FY2008 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$147,630
T32 · FY2008 · GM · contact PI
Myeloid cell function in muscle injury and repair$331,369
R01 · FY2007 · AR · contact PI
Regulation of sarcopenia and muscle dysfunction by nitric oxide$331,100
R01 · FY2007 · AR · contact PI
Training in Molecular, Cellular & Integrative Physiology$115,338
T32 · FY2007 · GM · contact PI
Training in Molecular, Cellular & Integrative Physiology$130,375
T32 · FY2006 · GM · contact PI
Myeloid Cell Function in Muscular Dystrophy$423,320
R01 · FY2005 · AR
Myeloid Cell Function in Muscle Injury and Repair$253,531
R01 · FY2005 · AR
Training in Molecular, Cellular &Integrative Physiology$130,375
T32 · FY2005 · GM
Myeloid Cell Function in Muscular Dystrophy$423,254
R01 · FY2004 · AR
Myeloid Cell Function in Muscle Injury and Repair$253,531
R01 · FY2004 · AR
Training in Molecular, Cellular &Integrative Physiology$130,375
T32 · FY2004 · GM
Myeloid Cell Function in Muscular Dystrophy$20,223
R01 · FY2004 · AR
Myeloid Cell Function in Muscular Dystrophy$362,188
R01 · FY2003 · AR
Myeloid Cell Function in Muscle Injury and Repair$253,531
R01 · FY2003 · AR
Training in Molecular, Cellular &Integrative Physiology$63,451
T32 · FY2003 · GM
Myeloid Cell Function in Muscular Dystrophy$362,188
R01 · FY2002 · AR
Myeloid Cell Function in Muscle Injury and Repair$253,531
R01 · FY2002 · AR
Myeloid Cell Function in Muscular Dystrophy$350,509
R01 · FY2001 · AR
Myeloid Cell Function in Muscle Injury and Repair$254,293
R01 · FY2001 · AR
REGULATION OF MYOTENDINOUS JUNCTION STRUCTURE$246,188
R01 · FY2001 · AR
REGULATION OF MYOTENDINOUS JUNCTION STRUCTURE$239,018
R01 · FY2000 · AR